Skip to main content
NRC
NASDAQ Industrial Applications And Services

NRC Health Declassifies Board of Directors, Enhancing Shareholder Accountability

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.18
Mkt Cap
$413.53M
52W Low
$9.755
52W High
$22.79
52W Position info
86% above low
Off High info
20% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NRC sits 86% above its 52-week low of $9.755.

Summary

NRC Health announced a corporate name change to formalize its brand and, more significantly, declassified its Board of Directors to enable annual director elections, a move generally favored by governance advocates.


Key Events · Corporate Governance and Compliance · NRC

  • Board Declassification Approved

    The Board of Directors has been declassified, transitioning from staggered three-year terms to annual elections for all directors, effective April 15, 2026.

  • Procedural Director Resignations

    Five directors submitted resignations effective immediately prior to the 2026 Annual Meeting to facilitate the declassification, with all incumbent directors nominated for re-election.

  • Corporate Name Change Formalized

    National Research Corporation formally changed its corporate name to NRC Health, aligning its legal identity with its established brand name used since 2016. The ticker symbol 'NRC' remains unchanged.

  • Executive Equity Award Amended

    An amendment was approved for CFO Shane Harrison's restricted stock award, permitting voting rights and dividend receipt on 172,000 unvested shares.


Analysis · NRC · Industrial Applications And Services

The company's decision to declassify its Board of Directors is a material corporate governance improvement. This change means all directors will now stand for annual re-election, increasing accountability to shareholders. While several directors submitted resignations, these were procedural to facilitate the declassification, and all incumbent directors have been nominated for re-election. This move aligns with best practices for corporate governance and may be viewed positively by institutional investors. Additionally, the company formalized its corporate name to NRC Health, aligning its legal identity with its established brand.

At the time of this filing, NRC was trading at $18.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $413.5M. The 52-week trading range was $9.76 to $22.79. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NRC - Latest Insights

NRC
Jun 29, 2026, 1:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.04
Real-time Price: $22.46 info
Change: +$1.42 (+7%) info
Market Cap: $506.174M info
NRC
Jun 12, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $18.79
Real-time Price: $22.46 info
Change: +$3.67 (+20%) info
Market Cap: $506.174M info
NRC
May 13, 2026, 4:09 PM EDT
Filing Type: 424B7
Importance Score:
9
Price at Filing: $18.52
Real-time Price: $22.46 info
Change: +$3.94 (+21%) info
Market Cap: $506.174M info
NRC
May 08, 2026, 9:44 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $18.69
Real-time Price: $22.46 info
Change: +$3.77 (+20%) info
Market Cap: $506.174M info
NRC
May 06, 2026, 11:51 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $18.23
Real-time Price: $22.46 info
Change: +$4.23 (+23%) info
Market Cap: $506.174M info